SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Clinical trials for SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear
Sign up with your email to follow new studies for SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare immune disease: drug combo shows promise in small study
Disease control CompletedThis study tested a combination of two drugs—interferon-gamma monoclonal antibody and dexamethasone—in 22 adults with a severe immune condition called refractory secondary HLH. The goal was to see if the treatment helps patients recover and how safe it is. Participants received t…
Matched conditions: SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug aims to calm dangerous immune storms in Still's and lupus patients
Disease control CompletedThis study tested a drug called emapalumab in 33 children and adults with macrophage activation syndrome (MAS), a life-threatening immune overreaction, linked to Still's disease or lupus. The goal was to see if the drug could safely control the condition and reduce the need for h…
Matched conditions: SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC